AJP - GI Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (November 5, 2009). doi:10.1152/ajpgi.00349.2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Taché, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Taché, Y.

Research Article

Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice

Lixin Wang,1,* Guillaume Gourcerol,2 Pu-Qing Yuan,2 S. Vincent Wu,3 Mulugeta Million,1 Muriel Larauche,4 and Yvette Taché5

1UCLA 2 3VA West Los Angeles Medical Center\ 4UCLA - Center for Neurobiology of Stress 5Center for Neurovisceral Sciences

Submitted 24 August 2009 ; revision received 16 October 2009 ; accepted in final form 2 November 2009

ABSTRACT

Peptide YY (PYY) antisecretory effect on intestinal epithelia is well established while less is known about its actions to influence colonic motility in conscious animals. We characterized changes in basal and stimulated colonic motor function induced by PYY-related peptides in conscious mice. PYY3-36, PYY and neuropeptipde Y (NPY) (8 nmol/kg) injected intraperitoneally (ip) inhibited fecal pellet output (FPO)/h during novel environment stress by 90%, 63% and 57% respectively while the Y1 preferring agonists, [Pro34]PYY and [Leu31,Pro34]NPY had no effect. Corticotrophin-releasing factor 2 receptor antagonist did not alter PYY3-36 inhibitory action. PYY and PYY3-36 significantly reduced restraint-stimulated defecation, and PYY3-36 inhibited high amplitude distal colonic contractions as recorded in restrained conscious mice for 1 h recorded by intraluminal pressure using a microtransducer. PYY suppression of 5-hydroxytryptophan (5-HTP, ip)-induced FPO and diarrhea was blocked by Y2 antagonist, BIIE0246, injected ip and mimicked by PYY3-36 but not [Leu31, Pro34]NPY. PYY3-36 also inhibited bethanechol-stimulated FPO and diarrhea. PYY3-36 inhibited basal FPO during nocturnal feeding period and light phase in fasted/refed mice for 2-3 h while the reduction of food intake lasted only for 1 h. PYY3-36 delayed gastric emptying after fasting-refeeding by 48% and distal colonic transit time by 104% while [Leu31,Pro34]NPY had no effect. In the proximal and distal colon, higher Y2 mRNA expression was detected in the mucosa than muscle layers and Y2 immunoreactivity was located in nerve terminals around myenteric neurons. These data established that PYY/PYY3-36 potently inhibits basal and stress/5-HT/cholinergic stimulated propulsive colonic motor function in conscious mice likely via Y2 receptors.

PYY3-36; stress; serotonin; bethanechol



* UCLA LixinWang{at}mednet.ucla.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.